Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Stability in IBD and IBS After Macrogol
NCT03395548Completed
- Sponsor
- Medical University of Graz
- Start
- Aug 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of macrogol (3 arms), sponsored by Medical University of Graz. Primary endpoint: Changes of the microbiome at 4 months. Started Aug 2017; status: completed.
02
Drugs
macrogol
Beyond the preview
Go deeper on NCT03395548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395548.